[Federal Register Volume 66, Number 189 (Friday, September 28, 2001)]
[Notices]
[Page 49643]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-24357]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Live Attenuated Virus Vaccine for 
Western Equine Encephalitis Virus, Eastern Equine Encephalitis Virus, 
and Venezuelan Equine Encephalitis Virus IE and IIIA Variants.

AGENCY: U.S. Army Medical Research and Materiel Command, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made for 
availability for licensing of U.S. Patent No. 6,261,570 entitled ``Live 
Attenuated Virus Vaccine for Western Equine Encephalitis Virus, Eastern 
Equine Encephalitis Virus, and Venezuelan Equine Encephalitis Virus IE 
and IIIA Variants'' and issued July 17, 2001. Foreign rights are also 
available (PCT/US98/10645). This patent has been assigned to the United 
States Government as represented by the Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: cDNAs coding for an infectious Western 
Equine Encephalitis virus (WEE) and infectious Venezuelan Equine 
Encephalitis virus variant IR (VEE IE) are disclosed in addition to 
cDNA coding for the structural proteins of Venezuelan Equine 
Encephalitis virus variant IIIA (VEE IIIA). Novel attenuating mutations 
of WEE and VEE IE and their uses are described. Also disclosed are 
attenuated chimearic alphavirus and their uses.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 01-24357 Filed 9-27-01; 8:45 am]
BILLING CODE 3710-08-M